(Q46208530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Experimental investigation of antibody-mediated clearance mechanisms of amyloid-beta in CNS of Tg-SwDI transgenic mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Vitaly Vasilevko

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Feng Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Mary Lou Previti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

William E Van Nostrand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

David H Cribbs

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

13376-13383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

High affinity binding of monoclonal antibodies to the sequential epitope EFRH of beta-amyloid peptide is essential for modulation of fibrillar aggregation

29 December 2019

cites work

1 reference

12 December 2020

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

12 December 2020

Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.

1 reference

12 December 2020

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

12 December 2020

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

12 December 2020

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.

1 reference

12 December 2020

Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors

1 reference

12 December 2020

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition

1 reference

12 December 2020

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

1 reference

12 December 2020

Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

1 reference

12 December 2020

Abeta immunization and anti-Abeta antibodies: potential therapies for the prevention and treatment of Alzheimer's disease

1 reference

12 December 2020

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

1 reference

12 December 2020

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid

1 reference

12 December 2020

Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation

1 reference

12 December 2020

Short-term beta-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP + PS1 mice.

1 reference

12 December 2020

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

1 reference

12 December 2020

Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease

1 reference

12 December 2020

Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice

1 reference

12 December 2020

Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor

1 reference

12 December 2020

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease

1 reference

12 December 2020

An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.

1 reference

12 December 2020

Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease

1 reference

12 December 2020

Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome

1 reference

12 December 2020

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

1 reference

12 December 2020

Current progress in beta-amyloid immunotherapy

1 reference

12 December 2020

Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease

1 reference

12 December 2020

Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide

1 reference

12 December 2020

Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders

1 reference

12 December 2020

Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging.

1 reference

12 December 2020

Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein

1 reference

12 December 2020

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide

1 reference

12 December 2020

Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa Double A beta in human A betaPP transgenic mice

1 reference

12 December 2020

Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral

1 reference

12 December 2020

Novel Abeta peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease

1 reference

12 December 2020

IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.

1 reference

12 December 2020

A dynamic relationship between intracellular and extracellular pools of Abeta

1 reference

12 December 2020

Novel approaches for immunotherapeutic intervention in Alzheimer's disease

1 reference

12 December 2020

Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models

1 reference

12 December 2020

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

1 reference

12 December 2020

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

12 December 2020

Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease

1 reference

12 December 2020

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

1 reference

12 December 2020

Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration

1 reference

12 December 2020

10.1523/JNEUROSCI.2788-07.2007

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18057195%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

18057195

1 reference